rethinkPeptides Search
Menu
Study breakdown

Antimicrobial Peptides Show Promise Against Drug-Resistant Dental Plaque Biofilms

evidence
The takeaway

Antimicrobial peptides offer broad-spectrum activity against oral biofilms—from cavities to implant infections—with low resistance risk, positioning them as alternatives to failing antibiotics.

5 biofilm types targeted

AMPs effective against cariogenic, periodontal, root canal, peri-implantitis, and Candida biofilms

What the researchers found

AMPs demonstrate effective disruption of cariogenic, periodontal, root canal, peri-implantitis, and Candida-associated oral biofilms with minimal resistance development.

Why it matters

Antibiotic resistance is making oral infections harder to treat. AMPs represent a fundamentally different antimicrobial approach that could reshape dental therapeutics if stability and delivery challenges are overcome.

How the study worked

Narrative review synthesizing laboratory and preclinical studies on AMP mechanisms and applications against oral biofilms.

What this study cannot tell us

Mostly preclinical evidence; AMP stability in the oral environment (saliva, enzymes, pH) remains a challenge. Cost and scalability of peptide production may limit clinical adoption.

How to read the evidence

Narrative review of predominantly in vitro and preclinical evidence; clinical trials in dental AMP applications are still limited.

When this study was published

Published in 2026, reviewing current state of the field.

The bigger picture

As antibiotic resistance accelerates globally, AMPs in dentistry exemplify a broader shift toward peptide-based antimicrobials across medicine, from wound care to implant coatings.

Questions still open

  • Can AMPs be formulated into practical dental products like mouthwashes or implant coatings?
  • Will modified AMPs maintain their low-resistance advantage in real-world clinical use?
  • How cost-effective are AMP-based treatments compared to conventional antibiotics?

Common questions

Why are antimicrobial peptides better than antibiotics for dental infections?
AMPs kill bacteria by physically disrupting their cell membranes, a mechanism that is much harder for bacteria to evolve resistance against compared to traditional antibiotics that target specific molecular pathways.
Are AMP mouthwashes or toothpastes available?
Not commercially yet. Researchers are working on stabilizing AMPs for the challenging oral environment (saliva, pH changes, enzymes), but clinical products are likely still years away.

Read the original research

The Role and Progress of Antimicrobial Peptides in Managing Oral Biofilms: A Narrative Review.

International dental journal, 76(1), 104022

Citation

Ciren, Deji; Xia, Xiaoyue; Zhu, Yuemeng; Hui, Sumin; Hong, Lihua. (2026). The Role and Progress of Antimicrobial Peptides in Managing Oral Biofilms: A Narrative Review.. International dental journal, 76(1), 104022. https://doi.org/10.1016/j.identj.2025.104022